2017/18 Content Experts
cSw student writers are required to identify and interview at least one researcher at the peer-reviewed publication level and are encouraged to identify and interview other bona fide content experts. Writers consult with their communications mentors regarding the selection and recruitment of content experts.
Content experts, broadly speaking, are highly credible individuals having demonstrated expertise in specific areas. In the cSw context, content experts have knowledge directly related to the topic a given cSw writer chooses and include, but aren’t necessarily limited to:
- Authors of peer-reviewed publications
- Interpreters of scientific and technologic concepts and/or data
- Researchers, bloggers, and officials, editors or writers associated with high quality science- and technology-related institutions, organizations, publications, or credible mass media that cover science
- KOLs (key opinion leaders)
- Inventors, developers, and commercializers of discoveries and advances in science and/or technology
- Investors in science- and technology-related endeavors
- Consumers (e.g., patients, physicians and other medical industry personnel)
- Members of advocacy groups
Dr. Joseph Vinetz
Dr. Joseph Vinetz is an infectious disease specialist based in La Jolla, California. He graduated from Yale University in 1991 and completed his training in internal medicine at Johns Hopkins University. He has been studying the malaria parasite for over 28 years and has been working on a candidate vaccine for malaria for over twenty years. His accomplishments aren’t limited to advancements in understanding in malaria as he has also been researching other tropical diseases like leptospirosis and brucellosis. In addition, Dr. Vinetz is a talented clarinetist.
Dr. Emily Goldberg
Dr. Emily Goldberg is a postdoctoral fellow at Yale University. She obtained her Ph.D. in the Nikolich-Zugich lab at the University of Arizona. Dr. Goldberg works in the field of immunology. More specifically, her research is focused on aging and metabolism. She started volunteering in labs in high school and kept researching as an undergrad and in grad school. Describing her experiences, she said “I got lucky,” with a laugh, before going on to detail one of the projects she worked on which sparked her interest in her current topic. When she isn’t in the lab, Dr. Goldberg might be found doing pottery or playing ultimate frisbee.
Dr. Briony Forbes
Dr. Briony Forbes received her Ph.D. from the University of Adelaide in biochemistry. She has held postdoctoral positions at the University of Adelaide, Discipline of Biochemistry and at CSIRO Division of Human Nutrition. She is interested in science that can change society and have positive impacts on the lives of others. She is passionate about the science of metabolism, insulin, and diabetes, as well as the biochemistry of cell signaling in cancer.
Dr. Henry Daniell
Dr. Henry Daniell is a professor and Interim Chair of the Department of Biochemistry at the University of Pennsylvania. To improve on the current production of vaccines and biopharmaceuticals, he pioneered and advanced the concept of expressing foreign genes in chloroplast DNA. These therapeutic proteins produced are used in treatments for diseases such as hemophilia and diabetes, as well as oral vaccines for infectious diseases such as polio, tuberculosis, and others, as well as tolerance for autoimmune disorders. His works have been featured in over 200 publications, and received numerous awards, patents, and grants.
Dr. Sujan Shresta
Dr. Sujan Shresta is an Associate Professor in the Division of Inflammation Biology at the La Jolla Institute for Allergy and Immunology. Dr. Shresta studies the immunology and virology of the Dengue and Zika virus and their connection to viral immunopathogenesis.
John Aitken is a microbiologist based in New Zealand. He became interested in Crohn’s after a scare with Crohn’s-like symptoms at the age of 23. As the Board Director of Otakaro Pathways, a research organization in New Zealand, Aitken developed a test to identify MAP in patients’ blood and has since been a crucial advocate for MAP research. He is driven by what he calls “Crohn’s mothers” — the distressed parents of kids who have Crohn’s.
Dr. Rodrick Chiodini
Dr. Rodrick Chiodini pioneered research into the association between Crohn’s and MAP in the 1980s as a researcher at the University of Connecticut and has been a key player in Crohn’s research and advocacy ever since. MAP research likely wouldn’t exist if not for Rod’s dedication.
Dr. Gwenaelle Géléoc
Dr. Gwenaelle Géléoc is a Research Associate in Otolaryngology and Neurobiology at Boston Children’s Hospital and Assistant Professor of Otolaryngology at Harvard Medical School. As a principal investigator of the Holt/Géléoc Lab, which she runs with her husband, she conducts research involving the structure and function of sensory hair cells in the inner ear. When she is not busy working in the lab or writing articles, Dr. Géléoc enjoys running and spending time with her two children.
Dr. Jae Park
Dr. Jae Park is a hematologist-oncologist at Memorial Sloan Kettering Cancer Center in New York City. He loves his work on the biology of blood cancers and enjoys talking with patients and helping them get better. He became interested in CAR T-cell therapy during his oncology fellowship when he saw the huge potential of this approach in battling cancer.
Dr. Robert Krikorian
Dr. Robert Krikorian is a Professor in the Department of Psychiatry & Behavioral Neuroscience and Director of the Cognitive Aging Program at the University of Cincinnati Academic Health Center. Interested by the relationships in the brain, Krikorian was curious as to if blueberries could improve cognitive functions in humans. Through his studies, he has conducted clinical research involving the effects of blueberries on cognitive performance, hoping to discover preventive measures to decrease the risk of Alzheimer’s. When he’s not busy in the lab, Dr. Krikorian enjoys traveling to the southwest, driving sports cars, and playing/watching baseball.
Dr. Lisa Abegglen
Dr. Lisa Abegglen is an Instructor at the University of Utah (Department of Pediatrics). She works closely with Dr. Joshua Schiffman and their team of scientists. Her work focuses on genetic cancer predisposition syndromes and comparative oncology. Currently, she is researching molecular mechanisms of cancer resistance in elephants to hopefully apply it to improve human health in the future. Her past experience as a drug discovery scientist in the industry will help with these efforts. She shares her passion for science with her children (4 and 6 years old), who enjoy visiting the lab.
Dr. Tim Bugg
Dr. Tim Bugg is a professor of Biological Chemistry at the University of Warwick in Coventry, England. He has studied enzymes involved in bacterial cell wall synthesis since his post-doctoral work at Harvard Medical School in 1989. He is excited to be part of a potential new breakthrough in treating antibiotic-resistant tuberculosis and hopes that it may save lives in the future.
Dr. Rosie Brown
Dr. Rosie Brown received her PhD in from the University of Otago in 2010 in the Department of Anatomy and the Department of Physiology. She is currently a Research Fellow at the University of Otago Medical School in Dunedin, New Zealand in the Department of Anatomy. Her research seeks to understand how a mother’s brain adapts during pregnancy through hormone signaling and other processes to facilitate a behavior change, allowing her to care for her young—an exciting area in the scientific community.